Jason Napodano, CFA @JNapodano 3m @nomorefor
Post# of 30025
Posted On: 08/05/2014 9:32:44 AM
Jason Napodano, CFA @JNapodano 3m
@nomorefor @solantey The revenue opportunity for LymPro under CLIA is large but it will take 6+ months to get incorporated into protocols.
Jason Napodano, CFA @JNapodano 2m
@nomorefor @solantey But I would expect meaningful revenues once incorporated into the trial design. Very rapid ramp once initiated.
Take that Sol.
@nomorefor @solantey The revenue opportunity for LymPro under CLIA is large but it will take 6+ months to get incorporated into protocols.
Jason Napodano, CFA @JNapodano 2m
@nomorefor @solantey But I would expect meaningful revenues once incorporated into the trial design. Very rapid ramp once initiated.
Take that Sol.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼